Table 3 Participant’s responses about the importance of the components of a telehealth business framework (Round two of the Delphi study)
No | Dimensions | Components | Subcomponents | Very important | Important | Neutral | Less important | Unimportant | Mean ± SD | Median (1st–3rd quartile) | Agreement |
|---|---|---|---|---|---|---|---|---|---|---|---|
Frequency (%) | Frequency (%) | Frequency (%) | Frequency (%) | Frequency (%) | |||||||
1 | Telehealth business prerequisites | Business initial requirements | Trust in idea registration centers | 4 (28.6) | 5 (35.7) | 4 (28.6) | 1 (7.1) | 0 | 3.85 ± 0.94 | 4 (3–4.75) | * |
2 | Time lag between the idea generation and manufacturing | 11 (78.6) | 3 (21.4) | 0 | 0 | 0 | 4.78 ± 0.42 | 5 (5–5) | ✓ | ||
3 | Telehealth business production | Licenses and permissions | General and optional licenses | 6 (42.9) | 8 (57.1) | 0 | 0 | 0 | 4.42 ± 0.51 | 4 (4–5) | ✓ |
4 | Telehealth business payments and costs | Cost structure | Other tangible and intangible costs | 9 (64.3) | 2 (14.3) | 3 (21.4) | 0 | 0 | 4.42 ± 0.85 | 5 (4–5) | ✓ |
5 | Pricing | Pricing by product manufacturer | 4 (28.6) | 8 (57.1) | 2 (14.3) | 0 | 0 | 4.14 ± 0.66 | 4 (4–4.75) | ✓ | |
6 | Pricing by an independent organization | 3 (21.4) | 6 (42.9) | 4 (28.6) | 1 (7.1) | 0 | 3.78 ± 0.89 | 4 (3–4) | * | ||
7 | Revenue making | Selling data | 4 (28.6) | 8 (57.1) | 1 (7.1) | 1 (7.1) | 0 | 4.07 ± 0.82 | 4 (4–4.75) | ✓ | |
8 | Telehealth business post-production services | Product evaluation | In-person feedback | 7 (50) | 3 (21.4) | 3 (21.4) | 0 | 1 (7.1) | 4.07 ± 1.20 | 4.5 (3.5–4.5) | * |
9 | Responsibility of telehealth services | Relative responsibility for providing telehealth services | 5 (35.7) | 7 (50) | 2 (14.3) | 0 | 0 | 4.21 ± 0.69 | 4 (4–5) | ✓ | |
10 | Product Protection | Patent registration | 3 (21.4) | 6 (42.9) | 4 (28.6) | 1 (7.1) | 0 | 3.78 ± 0.89 | 4 (3–4) | * | |
11 | Receiving certificate of excellence | 6 (42.9) | 5 (35.7) | 2 (14.3) | 1 (7.1) | 0 | 4.14 ± 0.94 | 4 (4–5) | ✓ | ||
12 | Product marketing | Marketing at scientific congresses and science and technology exhibitions | 7 (50) | 3 (21.4) | 3 (21.4) | 1 (7.1) | 0 | 4.14 ± 1.02 | 4.5 (3.5–4.5) | ✓ | |
13 | Making contracts | Non-commercial contracts | 1 (7.1) | 8 (57.1) | 4 (28.6) | 1 (7.1) | 0 | 3.64 ± 0.74 | 4 (3–4) | * |